title: Achromobacter xylosoxidans Bacteremia and Cellulitis: A Report of a Case.
abstract: Achromobacter xylosoxidans is a rare, opportunistic infection most commonly encountered in immunocompromised patients during hospitalization. Primary uncomplicated bacteremia, catheter-associated infections, and pneumonia have been reported as the most common clinical presentations; skin and soft tissue infections from A. xylosoxidans are rare. We describe a case of A. xylosoxidans presenting as cellulitis and bacteremia in an immunocompromised patient.
authors.affiliation: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Julia
authors.initials: J
authors.lastname: Dai
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Auris O
authors.initials: AO
authors.lastname: Huen
authors.affiliation: Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.|Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
authors.forename: Lori A
authors.initials: LA
authors.lastname: Kestenbaum
authors.affiliation: Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
authors.forename: Margaret D
authors.initials: MD
authors.lastname: Sarezky
authors.affiliation: Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
authors.forename: Carrie C
authors.initials: CC
authors.lastname: Coughlin
authors.affiliation: Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.|Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
authors.forename: Albert C
authors.initials: AC
authors.lastname: Yan
mesh_terms: D042441:Achromobacter denitrificans / Q000302:isolation & purification*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D002481:Cellulitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D017809:Fatal Outcome; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host / Q000502:physiology; D008297:Male; D009333:Neck / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology; D012772:Shock, Septic; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents